Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding this year's conference. More than 7,700+ heart rhythm professionals from around the world whose participation during Heart Rhythm 2022
May 17, 2022
Heart Rhythm 2022 Highlights
May 17, 2022 — Heart Rhythm 2022 has come to a close, and the Heart Rhythm Society has released some stats regarding…
Read More
Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA (icosapent ethyl) to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs
May 17, 2022
Research Shows Potential to Reduce Major Cardiovascular (CV) Events
May 17, 2022 — Amarin Corporation plc announced that research on the potential population health impact and cost-…
Read More
On the heels of its landmark valvular heart disease (VHD) prevalence abstract published in Journal of the American College of Cardiology (JACC), egnite, Inc. announced that it has expanded the company’s focus beyond structural heart disease into cardiovascular (CV) disease, starting with atrial fibrillation (AF).
May 17, 2022
egnite, Inc. Expands into Cardiovascular Disease Supported by New Data on the State of Care for Patients with Atrial Fibrillation
May 17, 2022 — On the heels of its landmark valvular heart disease (VHD) prevalence abstract published in Journal of…
Read More
Seamless integration and communication between Philips Ultrasound System - EPIQ CVxi - and Philips Image Guided Therapy System - Azurion - supports efficient fusion-imaging workflow for minimally-invasive treatment of structural heart disease
May 16, 2022
Philips EchoNavigator Helps Interventional Teams Treat Structural Heart Disease
May 16, 2022 — Philips, a global leader in health technology, announced at EuroPCR (17 - 20 May 2022, Paris, France)…
Read More
Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific from 1979 to 1999 and a corporate visionary in the minimally invasive surgery industry, passed away peacefully on May 14 just a few days before his 81st birthday. 
May 16, 2022
Boston Scientific Co-founder and Former CEO Passes Away
May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston…
Read More
Key members of the research collaboration: (from left) Prof Roger Foo (Programme Director, ATTRaCT, and Senior Group Leader, GIS), Dr Karin Conde-Knape (Senior Vice President, Global Drug Discovery, Novo Nordisk), Dr Rasmus Rabøl (Corporate Vice President, Global Translation, Novo Nordisk), Dr Natasha Michaelsen (Principal Scientist, Global Translation, Novo Nordisk), Prof Mark Richards (Director, Cardiovascular Research Institute, NUS, and Deputy Director, National University Heart Centre), Prof Derek Haus
May 16, 2022
A*STAR, NHCS, NUS, and Novo Nordisk to Collaborate on Cardiovascular Disease Research
May 16, 2022 — The Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and…
Read More
A substantial proportion of patients with COVID and shock had low CI despite preserved EF, suggesting underfilling of the LV, but this proportion was smaller in W2. This difference could not be explained by changes in PEEP between cohorts. This suggests that fluid management strategies may have been more aggressive in W2.
May 16, 2022
New Report Published Comparing Hemodynamics of Cardiac Shock in COVID-19 Patients in Pandemic’s First Vs. Second Wave
May 16, 2022 — A new report by a team of cardiologists from the Heart & Vascular Hospital, Hackensack Meridian…
Read More
Pump housing and impeller design. (A): (left) Axial flow pump: HeartMate II LVAD (taken from Figure 2 in the HeartMate II left ventricular assist system instructions for use). (B) (right) Centrifugal flow pump: HeartWare assist device (taken from Figure 2 in the HeartWare assist device patient manual).
May 16, 2022
Study Finds that Concurrent Tricuspid Valve Surgery and Left Ventricular Assist Device Implantation do not Appear to Lower the Incidence of Right Heart Failure
May 16, 2022 — Right heart failure (RHF) continues to be a major source of morbidity and mortality following left…
Read More
CRF Meeting Covering Structural Heart Disease Innovations Will Take Place June 8-10
May 16, 2022
Late-Breaking Science Announced for TVT 2022
May 16, 2022 — The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will…
Read More
Mavacamten estimated sales just shy of $1 billion if approved for common cardiomyopathy subtype, says GlobalData
May 13, 2022
Bristol Myers Squibb’s Mavacamten Poised to Stand unchallenged
May 13, 2022 — Bristol Myers Squibb’s mavacamten will stand rather unchallenged in the hypertrophic cardiomyopathy (HCM…
Read More
Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced successful completion of patient enrollment in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial which enrolled 110 patients at 21 sites globally
May 13, 2022
Acutus Medical Completes Enrollment in IDE Trial with its AcQBlate FORCE Sensing Ablation System
May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are…
Read More
Woon-Hong Yeo has developed a smarter stent. Georgia Tech Photo
May 13, 2022
Georgia Tech Researchers Develop Wireless Implantable Vascular Monitoring System
May 13, 2022 — Vascular diseases are public enemy number one: the leading killers worldwide, accounting for nearly a…
Read More
The Neurescue device is an FDA-approved device currently in use for patients with severe bleeding which will now be used in a new study to help increase survival rate for those who experience in-hospital cardiac arrests
May 13, 2022
MemorialCare Long Beach Medical Center Only Site in Nation to Offer ARISE-Study – New Experimental Treatment for In-Hospital Cardiac Arrest
May 13, 2022 — The MemorialCare Heart & Vascular Institute at Long Beach Medical Center has been designated the…
Read More
Training program is open to underrepresented groups including female, Black, Native American, Asian, South Asian, Hispanic and non-binary cardiologists
May 12, 2022
Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials
May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more …
Read More
The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032, expanding at a CAGR of 6.2% over the 2022-2032 time frame.
May 12, 2022
Cardiogenic Shock Market Outlook
The global cardiogenic shock market was valued at US$ 3.29 Bn in 2021, and is expected to reach US$ 6.32 Bn by 2032,…
Read More
Integrated patch offers ECG, heart rate, respiratory rate, and blood pressure monitoring for commercial research and development
May 12, 2022
Vivalink Announces World’s First Multi-Vital Blood Pressure Patch for Remote Patient Monitoring
May 12, 2022 — Vivalink, a leading provider of digital healthcare solutions, announced availability of the world’s…
Read More
Peter Mackrell, MD
May 12, 2022
Board Certified Vascular Surgeon Joins NDA Partners as Expert Consultant
May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified…
Read More
NIH-funded study explains factors linked to increased risk for heart attack or stroke among women who have pregnancy problems related to high blood pressure
May 11, 2022
Hypertensive Pregnancy Disorders Linked to Future Cardiac Events
May 11, 2022 — Women who experienced complications related to developing high blood pressure, or hypertension, during…
Read More
A microscopy picture of muscle cells in a normal heart (left) and muscle cells in a heart of a patient with hypertrophic cardiomyopathy (right). The black areas are single muscle cells. The muscle cells of the hypertrophic cardiomyopathy patient are bigger, and there is more space in between the cells (green), which is filled with scar tissues in the case of patients with hypertrophic cardiomyopathy. The blue indicates where the DNA of the cells can be found. Image courtesy of Anne de Leeuw, copyright Hubre
May 11, 2022
Single Cell RNA Sequencing Uncovers New Mechanisms of Heart Disease
May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a…
Read More
Gay Nord
May 11, 2022
Vital Heart & Vein Names Gay Nord, MHA as New CEO
May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now